Solid Biosciences
(NASDAQ) SLDB
Solid Biosciences Financials at a Glance
Market Cap
$1.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$191.78M
EPS (TTM)
-$1.95
P/E Ratio
-5.73
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$11.00
Volume
1,378,338.227
Open
$10.86
Price
$11.00
Volume
1,378,338.227
Open
$10.86
Previous Close
$11.00
Daily Range
$10.63 - $11.34
52-Week Range
$3.79 - $11.45
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.39 (Average)
Price
$11.00
Volume
1,378,338.227
Open
$10.86
Previous Close
$11.00
Daily Range
$10.63 - $11.34
52-Week Range
$3.79 - $11.45
Estimated Earnings Date
Aug 11, 2026
SLDB News
SLDB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Solid Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
121
CEO
Alexander Gery Cumbo
Website
www.solidbio.comHeadquarters
Cambridge, MA 02139, US
SLDB Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-74.45%
Return on Capital
-89.08%
Return on Assets
-45.35%
Earnings Yield
-17.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
98.45M
Volume
1.38M
Avg. Volume
1.67M
Financials (TTM)
Gross Profit
-$781.00K
Operating Income
-$196.46M
EBITDA
-$190.10M
Operating Cash Flow
-$171.67M
Capital Expenditure
-$1.19M
Free Cash Flow
-$172.86M
Cash & ST Invst.
$381.32M
Total Debt
$20.67M
Solid Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$395.00K
+2.9%
Gross Margin
0.00%
N/A
Market Cap
$1.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$9.07M
N/A
Employees
121
N/A
Net Income
-$56.74M
-44.4%
EBITDA
-$56.34M
-45.2%
Quarterly Fundamentals
Total Cash
$381.32M
+24.2%
Total Debt
$20.67M
-12.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$18.48M
-10.6%
Short Term Debt
$2.19M
-26.2%
Return on Assets
-45.35%
N/A
Return on Invested Capital
-50.04%
N/A
Free Cash Flow
-$47.40M
-48.2%
Operating Cash Flow
-$47.23M
-48.3%